[Acute purulent meningitis].
D000293:Adolescent; D000367:Age Factors; D000667:Ampicillin / Q000627:therapeutic use; D001118:Argentina; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D004341:Drug Evaluation; D005839:Gentamicins / Q000627:therapeutic use; D006192:Haemophilus Infections / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007612:Kanamycin / Q000627:therapeutic use; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000453:epidemiology; D008586:Meningitis, Pneumococcal / Q000188:drug therapy / Q000453:epidemiology; D008587:Meningitis, Viral / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D013444:Sulfisoxazole / Q000627:therapeutic use; D013492:Suppuration / Q000188:drug therapy
D005839:Gentamicins; D010406:Penicillins; D007612:Kanamycin; D002701:Chloramphenicol; D013444:Sulfisoxazole; D000667:Ampicillin
Meningitis aguda purulenta